Sponsor pipeline

Otsuka / Astex clinical trial pipeline

Get alerts when Otsuka / Astex's trials change

41 active trials 23 recruiting 22 Phase 3 10 disease areas 9 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-19
Trial terminated
Trial terminated: The study was terminated due to operational and scientific constraints. The termination was not based on safety concerns.
Enrollment reduced: 18 → 8 participants
Primary completion moved earlier: 2027-01-29 → 2026-07-10
Completion moved earlier: 2027-02-11 → 2026-07-17
NCT07329621 A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in… · Phase 1
2026-08-13
Primary completion pushed: 2026-06-09 → 2026-11-07
Completion pushed: 2026-06-15 → 2026-11-07
NCT07446400 A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone… · Phase 1
2026-08-13
Recruitment opened
NCT07713758 A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver… · Phase 1
2026-08-01
Enrollment reopened
NCT07525960 A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test… · Phase 1

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-08-26 NCT07786454 A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety… Phase 3 Not Yet Recruiting
2026-08-18 NCT07770815 Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy… Phase 3 Not Yet Recruiting
2026-08-17 NCT07767903 A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With… Phase 3 Recruiting
2026-08-12 NCT07759128 A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With… Phase 3 Recruiting
2026-08-12 NCT07759154 A Study to Test the Effects of Centanafadine in Adults With… Phase 3 Not Yet Recruiting

Active trials by phase

Phase 1
7
Phase 1/2
3
Phase 2
2
Phase 2/3
4
Phase 3
18
Not charted: 7 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 41

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07767903 A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With… Generalized Anxiety Disorder Recruiting 2026-08-17
NCT07759128 A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With… Generalized Anxiety Disorder Recruiting 2026-08-12
NCT04782258 A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days… Autosomal Recessive Polycystic Kidney (ARPKD) Recruiting 2026-08-07
NCT06894212 A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With… Schizophrenia Recruiting 2026-07-31
NCT06971731 A Study of JNT-517 in Participants With Phenylketonuria (PKU) Phenylketonuria Recruiting 2026-07-08
NCT07209761 A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant… Pulmonary Tuberculosis Recruiting 2026-05-06
NCT06628128 A Long-Term Study of JNT-517 in Participants With Phenylketonuria Phenylketonuria (PKU) Recruiting 2026-05-01
NCT07225712 A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia Schizophrenia Recruiting 2026-01-14
NCT07087327 A Long-term Trial of EB-1020 in Pediatric Patients With ADHD Attention-Deficit Hyperactivity Disorder(ADHD) Recruiting 2025-12-23
NCT06926829 A Long-term Trial of EB-1020 in Adult Patients With ADHD Attention Deficit Hyperactivity Disorder (ADHD) Recruiting 2025-08-03
NCT05325645 Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia Acute Schizophrenia Recruiting 2025-03-12
NCT07786454 A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety… Generalized Anxiety Disorder Not Yet Recruiting 2026-08-26
NCT07770815 Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy… IgA Nephropathy Not Yet Recruiting 2026-08-18
NCT07759154 A Study to Test the Effects of Centanafadine in Adults With… Attention-deficit/Hyperactivity Disorder Not Yet Recruiting 2026-08-12
NCT05248646 Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) Immunoglobulin A Nephropathy Active, Not Recruiting 2026-07-14
NCT07184645 A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis Atopic Dermatitis (AD) Not Yet Recruiting 2025-09-22
NCT07173478 A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in… Atopic Dermatitis (AD) Not Yet Recruiting 2025-09-15
NCT05326347 A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in… Schizophrenia Active, Not Recruiting 2024-10-30
Phase 2/3
NCT07086313 A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD Attention-Deficit Hyperactivity Disorder(ADHD) Recruiting 2025-12-23
NCT06589505 Software as a Medical Device for the Treatment of Patients With PTSD Post-Traumatic Stress Disorder, PTSD Recruiting 2025-11-21
NCT06931080 Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients Attention Deficit Hyperactivity Disorder (ADHD) Recruiting 2025-08-03
NCT05248659 Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) Immunoglobulin A Nephropathy Enrolling by Invitation 2026-05-05
Phase 2
NCT06740526 Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue IgA Nephropathy Recruiting 2025-04-06
NCT06928142 A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously… Sjogren Disease Active, Not Recruiting 2026-03-18
Phase 1/2
NCT06575426 A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in… Diabetes Mellitus, Type 1 Recruiting 2026-08-21
See all 41 active Otsuka / Astex trials with filters →

Disease areas by active trials

Schizophrenia (5) · ADHD (5) · Lupus (SLE) (3) · Anxiety (3) · Diabetes (2) · Atopic Dermatitis (2) · Myelodysplastic Syndromes (MDS) (1) · Multiple Myeloma (1) · Heart Disease (1) · Hypertension (1)

Get alerts when Otsuka / Astex's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free